Gene · 926
Papers3,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer. | Cancers (Basel) | 2026 | 41749825 | PubTator, text mining | PubMed |
| Single-Nucleus RNA Sequencing Reveals SPP1+ Macrophages Induce Cardiomyocyte Apoptosis to Promote Atrial Fibrillation Susceptibility. | J Cardiovasc Dev Dis | 2026 | 41745328 | PubTator, text mining | PubMed |
| The Bioinformatics and Experimental Analysis of CD276 for Prognosis and Immune Infiltrates in Colon Adenocarcinoma. | Cancer Rep (Hoboken) | 2026 | 41725032 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal transplant-associated T cells and myeloid cells in human liver transplantation. | Front Immunol | 2026 | 41716417 | PubTator, text mining | PubMed |
| Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer. | Cell Rep Med | 2026 | 41707645 | PubTator, text mining | PubMed |
| Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics. | J Immunother Cancer | 2026 | 41638872 | PubTator, text mining | PubMed |
| Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases. | Nat Immunol | 2026 | 41593242 | PubTator, text mining | PubMed |
| Optimal genetic feeder cell-expanded and engineered NK cell products are composed of CD56bright and CD56dim NK cells. | Cancer Immunol Immunother | 2026 | 41591514 | PubTator, text mining | PubMed |
| Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial. | Cancer Immunol Immunother | 2026 | 41591474 | PubTator, text mining | PubMed |
| CAR-T triggers TAM reeducation and adaptive anti-tumor response via TREM2 deficiency or CD40 agonist. | Cell Rep Med | 2026 | 41564864 | PubTator, text mining | PubMed |
| Mendelian randomization analysis of immune cell subsets and inflammatory cytokines in aplastic anaemia. | Ann Hematol | 2026 | 41555114 | PubTator, text mining | PubMed |
| Synthetic rewriting technologies in mammalian cells. | Nat Commun | 2026 | 41530163 | PubTator, text mining | PubMed |
| Elevated levels of SLC38A1 are correlated with an unfavorable prognosis, as well as accelerated cell proliferation and metastasis in lung adenocarcinoma. | BMC Cancer | 2026 | 41495694 | PubTator, text mining | PubMed |
| A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands. | Nat Commun | 2026 | 41484084 | PubTator, text mining | PubMed |
| Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativa. | Front Immunol | 2025 | 41766817 | PubTator, text mining | PubMed |
| Upregulation of interferon-γ activation in patients with anti-interferon-γ autoantibodies immunodeficiency syndrome: insights from single-cell analysis. | Front Immunol | 2025 | 41710026 | PubTator, text mining | PubMed |
| CelLink: integrating single-cell multi-omics data with weak feature linkage and imbalanced cell populations. | Nucleic Acids Res | 2025 | 41335468 | PubTator, text mining | PubMed |
| A knowledge-guided approach to recovering important rare signals from high-dimensional single-cell data. | bioRxiv | 2025 | 41256547 | PubTator, text mining | PubMed |
| DiffHiChIP: Identifying differential chromatin contacts from HiChIP data. | Cell Rep Methods | 2025 | 41187750 | PubTator, text mining | PubMed |
| Single-cell and spatial analysis reveals macrophage-T cell crosstalk in non-small cell lung cancer immunosuppression. | Transl Lung Cancer Res | 2025 | 41132964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/926/papers?page=3